564 related articles for article (PubMed ID: 35335310)
1. Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy.
Zhang C; Ma Y; Zhang J; Kuo JC; Zhang Z; Xie H; Zhu J; Liu T
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335310
[TBL] [Abstract][Full Text] [Related]
2. Physiological Barriers and Strategies of Lipid-Based Nanoparticles for Nucleic Acid Drug Delivery.
Hu M; Li X; You Z; Cai R; Chen C
Adv Mater; 2024 May; 36(22):e2303266. PubMed ID: 37792475
[TBL] [Abstract][Full Text] [Related]
3. Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases.
Zeng S; Chen Y; Zhou F; Zhang T; Fan X; Chrzanowski W; Gillies MC; Zhu L
Adv Drug Deliv Rev; 2023 Aug; 199():114965. PubMed ID: 37315899
[TBL] [Abstract][Full Text] [Related]
4. Advances in modification and delivery of nucleic acid drugs.
Wang J; Tan M; Wang Y; Liu X; Lin A
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):417-428. PubMed ID: 37643976
[TBL] [Abstract][Full Text] [Related]
5. Use of Microfluidics to Prepare Lipid-Based Nanocarriers.
Vogelaar A; Marcotte S; Cheng J; Oluoch B; Zaro J
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111539
[TBL] [Abstract][Full Text] [Related]
6. Lipid-based nucleic acid therapeutics with in vivo efficacy.
Sufian MA; Ilies MA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1856. PubMed ID: 36180107
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of nucleic acid therapeutics: Challenges, strategies, and opportunities.
Jiang X; Wang N; Liu C; Zhuo Y; Liang L; Gan Y; Yu M
Drug Discov Today; 2023 Apr; 28(4):103507. PubMed ID: 36690175
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery.
Mollé LM; Smyth CH; Yuen D; Johnston APR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1809. PubMed ID: 36416028
[TBL] [Abstract][Full Text] [Related]
9. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
10. Lipid‑based nanoparticles for the therapeutic delivery of non‑coding RNAs in breast cancer (Review).
Silva-Cázares MB; Saavedra-Leos MZ; Jordan-Alejandre E; Nuñez-Olvera SI; Cómpean-Martínez I; López-Camarillo C
Oncol Rep; 2020 Dec; 44(6):2353-2363. PubMed ID: 33125103
[TBL] [Abstract][Full Text] [Related]
11. Application of living free radical polymerization for nucleic acid delivery.
Chu DS; Schellinger JG; Shi J; Convertine AJ; Stayton PS; Pun SH
Acc Chem Res; 2012 Jul; 45(7):1089-99. PubMed ID: 22242774
[TBL] [Abstract][Full Text] [Related]
12. Lipid-based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review.
Khodaverdi H; Zeini MS; Moghaddam MM; Vazifedust S; Akbariqomi M; Tebyaniyan H
Curr Drug Deliv; 2022; 19(10):1012-1033. PubMed ID: 35078396
[TBL] [Abstract][Full Text] [Related]
13. Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner.
Van de Vyver T; Bogaert B; De Backer L; Joris F; Guagliardo R; Van Hoeck J; Merckx P; Van Calenbergh S; Ramishetti S; Peer D; Remaut K; De Smedt SC; Raemdonck K
ACS Nano; 2020 Apr; 14(4):4774-4791. PubMed ID: 32250113
[TBL] [Abstract][Full Text] [Related]
14. Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development.
Lu M; Xing H; Zheng A; Huang Y; Liang XJ
Acc Chem Res; 2023 Feb; 56(3):224-236. PubMed ID: 36624086
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
16. Recent advancements in lipid-mRNA nanoparticles as a treatment option for cancer immunotherapy.
Karmacharya P; Patil BR; Kim JO
J Pharm Investig; 2022; 52(4):415-426. PubMed ID: 35369363
[TBL] [Abstract][Full Text] [Related]
17. Lipid-based nanoparticles for nucleic acid delivery.
Li W; Szoka FC
Pharm Res; 2007 Mar; 24(3):438-49. PubMed ID: 17252188
[TBL] [Abstract][Full Text] [Related]
18. Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01.
Ashizawa AT; Cortes J
Expert Opin Drug Deliv; 2015 Jul; 12(7):1107-20. PubMed ID: 25539721
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles for nucleic acid delivery.
Ding Y; Jiang Z; Saha K; Kim CS; Kim ST; Landis RF; Rotello VM
Mol Ther; 2014 Jun; 22(6):1075-1083. PubMed ID: 24599278
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale platforms for messenger RNA delivery.
Li B; Zhang X; Dong Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
